• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Session Name:

  • P6: Aging, Dementia, and Behavioral Neurology: Alzheimer

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 6 - 10 of 13

  • Page:
  • 1
  • 2
  • 3

Top-line Results from evoke and evoke+: Two Phase 3, Randomized, Placebo-controlled Trials of Semaglutide in Participants with Early-stage Symptomatic Alzheimer’s Disease

Author:Cummings, Jeffrey L.   Atri, Alireza   Feldman, Howard H.   Sano, Mary   Zetterberg, Henrik   Mystkowski, Paul   Knop, Filip K.   Johannsen, Peter   León, Teresa   Abschneider, Rikke Mortensen   Scheltens, Philip   

Session Name:P6: Aging, Dementia, and Behavioral Neurology: Alzheimer's Disease: Beyond Anti-amyloid Therapeutics 3  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P6.006  

Author Institution:Chambers-Grundy Center for Transformative Neuroscience, Department of Brain Health, Kirk Kerkorian School of Medicine, University of Nevada Las Vegas, Las Vegas, NV  Banner Sun Health Research Institute, Sun City, AZ  Alzheimer’s Disease Cooperative Study, Department of Neurosciences, University of California San Diego, La Jolla, CA  Icahn School of Medicine At Mount Sinai, New York, NY  Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Molndal, Sweden  Novo Nordisk Inc., Plainsboro, NJ  Novo Nordisk A/S, Copenhagen, Denmark  Alzheimer Center, Department of Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands  

  • View Abstract
  • View Disclosure

Semaglutide Impacts Proteomic Signatures Related to Dementia Risk in the SELECT Cardiovascular Outcomes Trial

Author:Mystkowski, Paul   Jimenez Mausbach, Marti   Refsgaard, Jan Christian   Martino, Gabriel   Leon, Teresa   Tijms, Betty   Paterson, Clare   

Session Name:P6: Aging, Dementia, and Behavioral Neurology: Alzheimer's Disease: Beyond Anti-amyloid Therapeutics 3  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P6.007  

Author Institution:Novo Nordisk Inc., Plainsboro, NJ  Novo Nordisk A/S, Søborg, Denmark  Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, Netherlands  Standard BioTools, Boulder, CO  

  • View Abstract
  • View Disclosure

Anti-tau Therapies in Alzheimer’s Disease: Systematic Review and Meta-analysis of Advanced-phase Randomized Clinical Trials

Author:Silva, Rebeca   Martins Costa, Ian Félix   Trevisan Meira, Othon   Andreão, Filipi   Ogasawara Donato, Kenzo   de Sousa Toledo Matias, Manuella   

Session Name:P6: Aging, Dementia, and Behavioral Neurology: Alzheimer's Disease: Beyond Anti-amyloid Therapeutics 3  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P6.008  

Author Institution:Federal University of Paraíba, Paraíba, Brazil., João Pessoa, Brazil  Federal University of Paraíba, Paraíba, Brazil., Brazil  Institute of Neurology of Curitiba, Curitiba, PR, Brazil , Brazil  Federal University of Rio de Janeiro, Rio de Janeiro, Brazil, Rio de Janeiro, Brazil  Bahiana School of Medicine and Public Health, Brazil  Federal University of Paraíba, Paraíba, Brazil, Brazil  

  • View Abstract
  • View Disclosure

Repurposed Drugs for Alzheimer’s Disease: Integrating Mechanistic Efficacy and Global Feasibility Through a Translational Decision Matrix

Author:Younas, Salma   Mallepally, Abhigna   Sarath Chandra, Sankranthi   Jain, Aditya   Narsinghpura, Aditi   Sahu, Sweta   

Session Name:P6: Aging, Dementia, and Behavioral Neurology: Alzheimer's Disease: Beyond Anti-amyloid Therapeutics 3  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P6.009  

Author Institution:University of the Punjab, Lahore, Pakistan  Gandhi Hospital, Hyderabad, Wanaparthy, India  Kurnool Medical College, India  Shyam Shah Medical College, Rewa, Ujjain, India  Kasturba Medical College, Mangalore, Mumbai, India  JJM Medical College, Bhubaneswar, India  

  • View Abstract
  • View Disclosure

Correlations between Clinical and Brain Volume Effects of Oral Valiltramiprosate in APOE4/4 Homozygotes with MCI: Pre-specified Analyses of the Phase-3 APOLLOE4 78-Week Trial in APOE4/4 Homozygotes with Early Alzheimer’s Disease (AD)

Author:Sabbagh, Marwan   Abushakra, Susan   Tosun, Duygu   Watson, David   Power, Aidan   Liang, Earvin   MacSweeney, Emer   Boada, Merce   Bennys, Karim   Matias-Guiu, Jorge   Hey, John A.   Flint, Susan   Kesslak, J. Patrick   Bracoud, Luc   Bray, Margaret   Tolar, Martin   

Session Name:P6: Aging, Dementia, and Behavioral Neurology: Alzheimer's Disease: Beyond Anti-amyloid Therapeutics 3  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P6.010  

Author Institution:Barrow Neurological Institute, Phoenix, AZ  Alzheon, Inc., Framingham, MA  University of California San Francisc, CA  Alzheimer’s Research and Treatment Center, Wellington, FL  Re:Cognition Health, London, United Kingdom  International University of Catalunya, Barcelona, Spain  Hopital Gui de Chauliac - CHRU de Montpellier, Montpellier, France  Hospital Clinico San Carlos, Madrid, Spain  Clario, Inc., Philadelphia, PA  

  • View Abstract
  • View Disclosure

Displaying 6 - 10 of 13

  • Page:
  • 1
  • 2
  • 3

© 2015 Mira Smart Conference | http://www.mirasmart.com